Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
5
|
| pubmed:dateCreated |
1979-3-24
|
| pubmed:abstractText |
20 patients (12 female) with moderately severe essential hypertension [blood pressure during placebo treatment 181 +/- 6 (systolic), 107 +/- 3 (diastolic)] completed a double-blind, cross-over dose-titrated comparison of labetalol and methyldopa. Both drugs reduced lying and standing arterial blood pressure to a similar extent, although only labetalol reduced heart rate. Compliance was high (greater than 95%) with both drugs, and the incidence of subjective adverse effects was similar.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0031-6970
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
18
|
| pubmed:volume |
14
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
301-4
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:365543-Clinical Trials as Topic,
pubmed-meshheading:365543-Double-Blind Method,
pubmed-meshheading:365543-Ethanolamines,
pubmed-meshheading:365543-Female,
pubmed-meshheading:365543-Humans,
pubmed-meshheading:365543-Hypertension,
pubmed-meshheading:365543-Labetalol,
pubmed-meshheading:365543-Male,
pubmed-meshheading:365543-Methyldopa,
pubmed-meshheading:365543-Placebos
|
| pubmed:year |
1978
|
| pubmed:articleTitle |
Labetalol, a cross-over double blind controlled trial.
|
| pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial
|